EP1392657A4 - PROTEASE INHIBITORS - Google Patents
PROTEASE INHIBITORSInfo
- Publication number
- EP1392657A4 EP1392657A4 EP01275089A EP01275089A EP1392657A4 EP 1392657 A4 EP1392657 A4 EP 1392657A4 EP 01275089 A EP01275089 A EP 01275089A EP 01275089 A EP01275089 A EP 01275089A EP 1392657 A4 EP1392657 A4 EP 1392657A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25250800P | 2000-11-22 | 2000-11-22 | |
US252508P | 2000-11-22 | ||
PCT/US2001/051647 WO2003053331A2 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1392657A2 EP1392657A2 (en) | 2004-03-03 |
EP1392657A4 true EP1392657A4 (en) | 2004-03-10 |
Family
ID=22956303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01275089A Withdrawn EP1392657A4 (en) | 2000-11-22 | 2001-11-19 | PROTEASE INHIBITORS |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1392657A4 (es) |
JP (1) | JP2005513083A (es) |
KR (1) | KR20040004445A (es) |
CN (1) | CN1635903A (es) |
AR (1) | AR034278A1 (es) |
AU (1) | AU2001298052A1 (es) |
BR (1) | BR0115473A (es) |
CA (1) | CA2436850A1 (es) |
CZ (1) | CZ20031403A3 (es) |
HU (1) | HUP0301964A3 (es) |
IL (1) | IL155997A0 (es) |
MX (1) | MXPA03004542A (es) |
NO (1) | NO20032328L (es) |
PL (1) | PL366232A1 (es) |
UY (1) | UY27032A1 (es) |
WO (1) | WO2003053331A2 (es) |
ZA (1) | ZA200303848B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
CA2404206A1 (en) | 2000-03-21 | 2001-09-27 | Smithkline Beecham Corporation | Protease inhibitors |
AU2001268407A1 (en) * | 2000-06-14 | 2001-12-24 | Smithkline Beecham Corporation | Protease inhibitors |
KR20100023948A (ko) | 2007-06-08 | 2010-03-04 | 닛뽕 케미파 가부시키가이샤 | 뇌동맥류의 치료 또는 예방약 |
JPWO2009054454A1 (ja) | 2007-10-24 | 2011-03-03 | 国立大学法人 東京医科歯科大学 | カテプシン阻害剤を有効成分として含有するToll様受容体のシグナル伝達の調整剤 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038687A1 (en) * | 1998-12-23 | 2000-07-06 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001095911A1 (en) * | 2000-06-14 | 2001-12-20 | Smithkline Beecham Corporation | Protease inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2404206A1 (en) * | 2000-03-21 | 2001-09-27 | Smithkline Beecham Corporation | Protease inhibitors |
-
2001
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/cs unknown
- 2001-11-19 CN CNA018220533A patent/CN1635903A/zh active Pending
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/hu unknown
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 IL IL15599701A patent/IL155997A0/xx unknown
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/pt not_active Application Discontinuation
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/ja not_active Withdrawn
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/es unknown
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/ko not_active Application Discontinuation
- 2001-11-19 PL PL01366232A patent/PL366232A1/xx not_active Application Discontinuation
- 2001-11-20 AR ARP010105409A patent/AR034278A1/es unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/es not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/no unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038687A1 (en) * | 1998-12-23 | 2000-07-06 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001095911A1 (en) * | 2000-06-14 | 2001-12-20 | Smithkline Beecham Corporation | Protease inhibitors |
Also Published As
Publication number | Publication date |
---|---|
EP1392657A2 (en) | 2004-03-03 |
UY27032A1 (es) | 2002-07-31 |
JP2005513083A (ja) | 2005-05-12 |
IL155997A0 (en) | 2003-12-23 |
ZA200303848B (en) | 2004-06-28 |
NO20032328L (no) | 2003-07-02 |
CA2436850A1 (en) | 2003-07-03 |
HUP0301964A2 (en) | 2007-02-28 |
HUP0301964A3 (en) | 2007-09-28 |
CZ20031403A3 (cs) | 2003-10-15 |
WO2003053331A3 (en) | 2003-11-13 |
NO20032328D0 (no) | 2003-05-22 |
BR0115473A (pt) | 2004-09-28 |
AR034278A1 (es) | 2004-02-18 |
AU2001298052A1 (en) | 2003-07-09 |
MXPA03004542A (es) | 2003-09-10 |
CN1635903A (zh) | 2005-07-06 |
KR20040004445A (ko) | 2004-01-13 |
PL366232A1 (en) | 2005-01-24 |
WO2003053331A2 (en) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2002002593A0 (en) | Protease inhibitors | |
GB0125445D0 (en) | Protease Inhibitors | |
IL215890A0 (en) | Peptidomimetic protease inhibitors | |
IL153421A0 (en) | Protease inhibitors | |
EP1235577A4 (en) | PROTEASE INHIBITORS | |
EP1232155A4 (en) | PROTEASE INHIBITORS | |
IL151087A0 (en) | Protease inhibitors | |
EP1229915A4 (en) | PROTEASE INHIBITORS | |
EP1231921A4 (en) | PROTEASE INHIBITORS | |
EP1229912A4 (en) | PROTEASE INHIBITORS | |
EP1229914A4 (en) | PROTEASE INHIBITORS | |
EP1229911A4 (en) | PROTEASE INHIBITORS | |
EP1351930A4 (en) | PROTEASE INHIBITORS | |
EP1161237A4 (en) | PROTEASE INHIBITORS | |
EP1233771A4 (en) | PROTEASE INHIBITORS | |
EP1173429A4 (en) | PROTEASE INHIBITORS | |
EP1401453A4 (en) | PROTEASE INHIBITORS | |
EP1231923A4 (en) | PROTEASE INHIBITORS | |
HUP0301964A3 (en) | Protease inhibitors | |
IL155961A0 (en) | Cysteine protease inhibitors | |
EP1232154A4 (en) | PROTEASE INHIBITORS | |
EP1231922A4 (en) | PROTEASE INHIBITORS | |
AU6407701A (en) | Serine protease inhibitors | |
GB0009123D0 (en) | Protease inhibitor | |
ZA200207478B (en) | Protease inhibitors. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030620 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040127 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 31/55 B Ipc: 7C 07D 495/04 B Ipc: 7C 07D 405/14 B Ipc: 7C 07D 223/08 A |
|
18D | Application deemed to be withdrawn |
Effective date: 20040414 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1063632 Country of ref document: HK |
|
D18D | Application deemed to be withdrawn (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
R18D | Application deemed to be withdrawn (corrected) |
Effective date: 20050531 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1063632 Country of ref document: HK |